India News Network·3 min read·medium

India Approves Qdenga Dengue Vaccine Amid Rising Cases

India Approves Qdenga Dengue Vaccine Amid Rising Cases
AI Summary

India has approved the Qdenga vaccine to combat rising dengue fever cases, particularly in high-risk regions like Karnataka. Medical experts emphasize that the vaccine, combined with mosquito control, is a vital tool for reducing hospitalizations.

Bengaluru: The Drugs Controller General of India (DCGI) has granted approval for Qdenga, a dengue vaccine aimed at lowering the risk of infection, severe disease, and hospitalisation. Local medical professionals have praised the approval as a major advancement in public health, particularly during peak periods of dengue transmission.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in

India Approves Qdenga Dengue Vaccine Amid Rising Cases — Headlinne — headlinne